Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

This company has been marked as potentially delisted and may not be actively trading.

Kezar Life Sciences (KZR) News Today

Kezar Life Sciences logo

KZR Latest News

Kezar Life Sciences Inc
Kezar Life Sciences (NASDAQ:KZR) Upgraded at Wall Street Zen
Kezar Life Sciences Announces Major Workforce Reduction
Kezar Life Sciences Repays Loan, Ends Agreement
Kezar Life Sciences Says FDA Lifts Clinical Hold
Kezar Life Sciences price target lowered to $7 from $9 at Wells Fargo
Kezar Life Sciences reports topline results from PORTOLA trial
TD Cowen Keeps Their Buy Rating on Kezar Life Sciences (KZR)
Positive Report for Kezar Life Sciences (KZR) from William Blair
William Blair Sticks to Its Hold Rating for Kezar Life Sciences (KZR)
Kezar Life Sciences files $400M mixed securities shelf
Kezar Life Sciences price target lowered to $9 from $11 at Wells Fargo
Kezar Life Sciences (KZR) Receives a Hold from H.C. Wainwright
Kezar struck again with second FDA hold
Get Kezar Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KZR and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KZR Media Mentions By Week

KZR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KZR
News Sentiment

-0.25

0.45

Average
Medical
News Sentiment

KZR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KZR Articles
This Week

2

1

KZR Articles
Average Week

Get the Latest News and Ratings for KZR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kezar Life Sciences and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:KZR) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners